Open AccessChemoprevention and Treatment of Pancreatic Cancer: Update and Review of the Literature
Author(s) -
Julia Benzel,
Volker Fendrich
Publication year - 2018
Publication title -
digestion
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.882
H-Index - 75
eISSN - 1421-9867
pISSN - 0012-2823
DOI - 10.1159/000485741
Subject(s) - medicine , pancreatic intraepithelial neoplasia , pancreatic cancer , aspirin , disease , cancer , metformin , curcumin , oncology , bioinformatics , pharmacology , pancreatic ductal adenocarcinoma , insulin , biology
Pancreatic ductal adenocarcinoma is one of the most lethal types of cancer with a 5-year survival rate of around 7%. Due to the relatively poor prognosis, the potential need of an effective chemoprevention is highly needed.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom